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Abstract Our previous study has revealed that dioscin, a
compound with anti-inflammatory, lipid-lowering, anti-
cancer and hepatoprotective effects, may induce autophagy
in hepatoma cells. Autophagy is a lysosomal degradation
pathway that is essential for cell survival and tissue
homeostasis. In this study, the role of autophagy and
related signaling pathways during dioscin-induced apop-
tosis in human lung cancer cells was investigated. Results
from 40-6-diamidino-2-phenylindole and annexin-V/PI
double-staining assay showed that caspase-3- and caspase-
8-dependent, and dose-dependent apoptoses were detected
after a 24-h dioscin treatment. Meanwhile, autophagy was
detected as early as 12 h after an exposure to low-dose
dioscin, as indicated by an up-regulated expression of LC3-
II and beclin-1 proteins. Blockade of autophagy with
bafilomycin A1 or 3-methyladenine sensitized the A549
and H1299 cells to apoptosis. Treatment of A549 and
H1299 cells with dioscin caused a dose-dependent increase
in ERK1/2 and JNK1/2 activity, accompanied with a
decreased PI3K expression and decreased phosphorylation
of Akt and mTOR. Taken together, this study demonstrated
for the first time that autophagy occurred earlier than
apoptosis during dioscin-induced human lung cancer cell
line apoptosis. Dioscin-induced autophagy via ERK1/2 and
JNK1/2 pathways may provide a protective mechanism for
cell survival against dioscin-induced apoptosis to act as a
cytoprotective reaction.
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Introduction
Dioscin, plant steroidal saponin, abundantly exists in some
medicinal plants, such as Dioscorea nipponica Makino and
Dioscorea zingiberensis Wright, has been widely used as an
important raw material for the synthesis of steroid hormone
drugs (Brautbar and Williams 2002). Previous researches
have demonstrated that this compound has anti-inflamma-
tory, lipid-lowering, anticancer and hepatoprotective effects
(Wang et al. 2007a, b; Sautour et al. 2004; Kaskiw et al.
2009; Lu et al. 2011). Several previous reports revealed that
dioscin was able to induce apoptosis in various carcinoma
cell lines (Lin et al. 2011; Choi et al. 2010; Yu et al. 2003).
Dioscin may induce apoptosis via inhibition of Bcl-2 and
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activation of caspase-9 and caspase-3 in Hela cells (Cai
et al. 2002), as well as generation of reactive oxygen species
(ROS) and apoptosis in HL-60 cells (Wang et al. 2007a, b).
Furthermore, it could also significantly inhibit P-glycopro-
tein expression, as a potent multidrug resistance reversal
agent and decrease the resistance degree of HepG2/adria-
mycin cells (Sun et al. 2011). However, the effect of dioscin
on the autophagy-related events of human lung cancer cells
has not been clearly clarified.
As a major intracellular degradation mechanism,
autophagy is activated under stress conditions to promote
survival during starvation or lead to programmed cell death
type II under specific conditions such as the inhibition of
apoptosis (Ivanov et al. 2007; da Rocha et al. 2001; Chua
and Choo 2011). Autophagy is initiated by the engulfment
of large sections of cytoplasm by a crescent-shaped
phagophore to form autophagosomes, which then undergo
acidification after maturation to become acidic vesicular
organelles (AVOs) (Liu and Lenardo 2007). The final
fusion of these autophagosomes with lysosomes leads to
their maturation into autophagolysosomes followed by the
digestion of their components by lysosomal hydrolases
(Kanzawa et al. 2003; Chang et al. 2007; Gorka et al.
2005). It is now believed that autophagy has broader
importance in regulating growth and maintaining homeo-
stasis in multicellular organisms. Defective autophagy
contributes to pathogenesis of a number of diseases,
including myopathies, neurodegenerative diseases and
some forms of cancers (Kelekar 2005). Several reports
showed that an induction of autophagy appears to facilitate
therapy-induced killing of tumor cells (Longo et al. 2008;
Ko et al. 2009). For example, temozolomide, a pro-auto-
phagic drug, has proven to be a promising candidate for
selective killing of apoptosis-resistant glioblastomas
(Kanzawa et al. 2004). The aim of the present study was to
characterize the effects of dioscin and further determine the
molecular mechanism cross talk between autophagy and
apoptosis in dioscin-induced cytotoxicity.
Materials and methods
Chemicals
Dioscin of over 98 % purity was purchased from China
Langchem INC. (St. Caliun, Shanghai). Stock solution of
dioscin was made at 10 mM concentration in dimethyl
sulfoxide (DMSO) (Sigma, St. Louis Co.) and stored at
-20 C. The final concentration of DMSO for all treat-
ments was less than 0.1 %. 3-(4,5-dimethylthiazol-2-y1)-
2,5-diphenyltetrazolium bromide (MTT), bafilomycin
A1 (BafA1), 40-6-diamidino-2-phenylindole (DAPI) and
3-methyladenine (3-MA) were obtained from Sigma
Chemical Co. (St. Louis, MO, USA). General caspase
inhibitor Z-VAD-FMK was purchased from Promega
(Madison, WI, USA). Specific inhibitors for caspase-3
(Z-DEVE-FMK), caspase-8 (Z-IETD-FMK) or caspase-9
(Z-LEHO-FMK) were purchased from BioVision (Moun-
tain View, CA).
Cell culture
A549 and H1299, human nonsmall cell lung cancer cell
line, obtained from the Food Industry Research and
Development Institute (Hsinchu, Taiwan), were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco
BRL, Grand Island, NY, USA) supplemented with 10 %
fetal bovine serum (FBS), 1 mM glutamine, 1 % penicillin/
streptomycin, 1.5 g/l sodium bicarbonate and 1 mM
sodium pyruvate (Sigma, St. Louis, Mo, USA) and main-
tained at 37 C in a humidified atmosphere of 5 % CO2.
Cell cytotoxicity assay
The effect of dioscin on cell growth was assayed by the
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazo-
lium bromide) method, as previously described (Ho et al.
2011). Briefly, cells were cultured in 24-well plates
(5 9 104/well) and stimulated with different concentra-
tions of dioscin (0, 1.25, 2.5 and 5 lM) in culture media.
After 24 or 48 h of dioscin stimulation, MTT was added to
each well (0.5 mg/ml final concentration) with a further
incubation for 4 h. The viable cell number was directly
proportional to the production of formazan following the
solubilization with isopropanol. The color intensity was
measured at 570 nm. Each condition was performed in




Cells (4 9 105/well) were grown on 6-well cell culture
dish overnight. After being subjected to indicate treatment,
cells were fixed with 2 % paraformaldehyde (Sigma, USA)
for 20 min and then incubated with 0.5 % Triton X-100
(Sigma, USA) for 10 min. Extensive PBS washing was
conducted between each reaction to remove any residual
solvent. Cells were subjected to DAPI staining for 10 min
and then observed under fluorescence microscopy equipped
with filters for UV.
Cell cycle analysis
To determine the effect of dioscin on cell cycle, cells
(5 9 105/ml) were first cultured in serum-free medium for
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starvation at 18 h and then exposed to dioscin for 24 h.
Then cells were washed, fixed with 70 % ethanol, incu-
bated for 30 min in the dark at room temperature with
propidium iodide (PI) buffer (4 lg/ml PI, 1 % Triton
X-100, 0.5 mg/ml RNase A in PBS) and then filtered
through a 40-lm nylon filter (Falcon, USA). The cell cycle
distribution was analyzed for 10,000 collected cells by a
FACS Vantage flow cytometer that uses the CellQuest
acquisition and analysis program (Becton Dickinson
FACSCalibur).
Annexin-V/PI double-staining
To detect apoptosis in human lung cancer cells after
exposure to dioscin, an FITC annexin-V Apoptosis
Detection Kit I (BD Biosciences, USA) was used to
quantify cell number in different stages of cell death
(Casciola-Rosen et al. 1996). Briefly, 1 9 105 cells were
resuspended in 100 ll 19 binding buffer (0.01 M Hepes/
NaOH (pH 7.4), 0.14 M NaCl, 2.5 mM CaCl2). After the
addition of FITC annexin-V and PI (5 ll each), the cell
suspension was gently vortexed and incubated for 15 min
at room temperature in the dark. Four hundred microliters
of 19 binding buffer was added to each tube and analyzed
by flow cytometry within 1 h.
Quantification of acidic vesicular organelle (AVO)
formation
The occurrence of AVOs was assessed by a previously
described method (Zhan et al. 2012). Briefly, dioscin-
treated cells were washed with PBS, followed by staining
with 1 lg/ml acridine orange (diluted in PBS containing
5 % FBS; Sigma) for 15 min. Afterward, cells were
washed with PBS. For quantification of AVOs, acridine
orange-stained cells were harvested, washed twice with
PBS, resuspended in PBS containing 5 % FBS and then
analyzed by flow cytometry.
Western blot analysis
Cell lysates were separated in a 10 or 15 % polyacrylamide
gel and transferred onto a PVDF membrane (Millipore
Corporation, Milford, MA, USA). The blot was subse-
quently incubated with 3 % nonfat milk in PBS for 1 h to
block nonspecific binding and probed with a corresponding
antibody against a specific protein (antibodies for Bcl-2,
beclin-1, phospho-mTOR and mTOR were from Cell Sig-
naling; anti-LC3 was from NOVUS; anti-caspase-3 was
from Invitrogen; antibodies for PARP, caspase-8 and cas-
pase-9 were from Santa Cruz; antibodies for PI3K, Akt,
phospho-Akt, p38, JNK1/2 and b-actin were from BD
Biosciences; antibodies for ERK1/2, phospho-ERK1/2,
phospho-p38 and phospho-JNK were from Millipore
Corporation) for 37 C at 2 h or overnight at 4 C and then
with an appropriate peroxidase-conjugated secondary
antibody for 1 h. After the final washing, signal was
developed by ECL detection system, and relative photo-
graphic density was quantitated by a gel documentation
and analysis (AlphaImager 2000, Alpha Innotech Corpo-
ration, San Lean 189 dro, CA, USA).
In situ immunofluorescence assay
Cells were seeded into 6-well dish at a density of 4 9 105
cells per dish and treated with dioscin of an indicated
concentration for 12 h. After the incubation, cells were
fixed with 2 % paraformaldehyde for 20 min and then
incubated with 0.5 % Triton X-100 for 10 min. PBS
washing was conducted between each reaction to remove
any residual solvent. Afterward, fixed cells were incubated
with 4 % BSA at room temperature for 2 h and then with
the appropriate primary antibodies at 4 C overnight. After
overnight incubation, cells were washed and then incubated
with Alexa Fluor 488-conjugated affinipure goat anti-rabbit
IgG secondary antibody (Jackson Immuno Research, West
Grove, PA, USA) with light protection. Meanwhile,
another set of cells was subjected to DAPI staining for
10 min without antibody reaction. At the end of incubation,
cells were observed under fluorescence microscopy
equipped with filters for UV and Blue 488 nm.
Statistical analysis
Statistical significances of differences throughout this study
were analyzed by one-way ANOVA test. A P value \ 0.05
was considered to be statistically significant. Values rep-
resent the mean ± standard deviation, and the experiments
were repeated three times.
Results
Cytotoxic effects and morphological features
of dioscin-treated human lung cancer cell lines
The chemical structure of dioscin was shown in Fig. 1a. To
determine the cytotoxicity and the effect of cell prolifera-
tion of dioscin on A549 and H1299 cells, cells were treated
with different concentrations of dioscin (0–5 lM) for 24 or
48 h. Results from MTT assay for cell viability revealed
that dioscin inhibited growth in a dose-dependent and time-
dependent manner (Fig. 1b, c). Furthermore, results from
microscopic observation of cell morphology, as shown in
Fig. 1d, indicated that significant cell death was observed
at 24 h after dioscin treatment.
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Dioscin-induced cell apoptosis is dependent
on the activation of caspase-3 and caspase-8 in human
lung cancer cell lines
To determine whether the inhibitory effect of cell prolif-
eration of dioscin is associated with induction of cell
apoptosis, DAPI staining assay was performed to reveal the
presence of nuclei condensing and apoptotic bodies in
dioscin-treated A549 and H1299 cells in a dose-dependent
manner (Fig. 2a). Further characterization analysis of the
cell cycle by flow cytometry showed a dose-dependent
increased accumulation of cell population in sub-G1 phase
after a 24-h treatment with 2.5 and 5 lM of dioscin
(Fig. 2b). Meanwhile, annexin-V and PI double-staining
displayed an increased percentage of apoptotic cells after a
24-h treatment of dioscin of 2.5 and 5 lM (Fig. 2c),
respectively. Furthermore, cleaved PARP and cleaved
caspase-3 and caspase-8 were also detected in dioscin-
treated A549 and H1299 cells, accompanied with decreased
expression levels of Bcl-2 and anti-apoptosis protein
(Fig. 2d, e). To further confirm the involvement of caspase
activation in dioscin-induced apoptosis, caspase-specific
inhibitors were employed to show that a pretreatment with
caspase-3- or caspase-8-specific inhibitor could effectively
attenuate dioscin-induced cell apoptosis, while caspase-9
inhibitor has no effect (Fig. 2f). These data suggested that
dioscin-induced apoptosis is dependent on the activation of
caspase-3 and caspase-8, but not that of caspase-9 in human
lung cancer cell lines.
Induction of autophagy in dioscin-treated human lung
cancer cell lines
Previous data showed that cells displayed characteristic
apoptotic changes in cell morphology after 24-h treatment
with dioscin. Moreover, various numbers of cytoplasmic
vacuoles were observed at 12 h after dioscin treatment
(Fig. 3a). Beclin-1, a Bcl-2-interacting protein, also binds
Fig. 1 Cytotoxic effect of
dioscin in human lung cancer
cell lines. a Structure of dioscin.
b Cell viability analysis of A549
and H1299 cells c cultured in
the presence of dioscin for 24
and 48 h by MTT assay. d A549
and H1299 cells were treated
with different concentrations of
dioscin (0–5 lM) for 24 h and
then observed under
microscopes to reveal cell death
in a dose-dependent manner.
Data represent mean of three
determinations per condition
repeated three times. Results are
shown as mean ± SD
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to class III PI3Ks and helps to regulate autophagy.
Therefore, the formation of LC3 puncta was analyzed by
in situ immunostaining. As shown in Fig. 3b, cytoplasmic
LC3 formation was observed in dioscin-treated A549 and
H1299 cells, which indicated the formation of autophago-
somes. A significant change in LC3 puncta formation was
found at 12 h after dioscin treatment at a concentration of
5 lM. According to a previous study, autophagy is char-
acterized by the formation of numerous acidic vesicles that
are called AVOs (Zhan et al. 2012). Therefore, the next
step is to assess whether dioscin may induce the formation
of numerous AVOs in A549 and H1299. For quantification,
cells with AVOs showed enhanced red fluorescence ana-
lyzed by flow cytometry, which significantly increased in a
dose-dependent manner after treatment with dioscin
(Fig. 3c). In addition, increased LC3-II and beclin-1 pro-
tein expression was observed in dioscin-treated A549 and
H1299 cells, and such increase was in a dose-dependent
manner (Fig. 3d).
Dioscin-induced cell death was not rescued
by treatment autophagy inhibitor
In this part of study, 3-MA, an autophagy inhibitor by
blocking autophagosome formation via the inhibition of
type III PI-3K, was used for a pretreatment. As results
shown in Fig. 4a, 1 h pretreatment with 3-MA of 5 mM
before a dioscin treatment for 24 h led to a decreased level
of dioscin-induced LC3-II protein, as well as increased
levels of cleaved caspase-8 and cleaved caspase-3. 3-MA
pretreatment also increased the inhibitory effect of dioscin
on cell proliferation (Fig. 4b) while the percentage of
annexin-V-positive cells was increased (Fig. 4c). Bafilo-
mycin A1 (BafA1), an inhibitor of vacuolar ATPase and
Fig. 2 Dioscin-induced cell apoptosis in human lung cancer cell
lines. a Cells were treated with different concentrations of dioscin
(0–5 lM) for 24 h and then subjected to DAPI staining for DNA
(blue areas) by fluorescence microscopy. b A549 and H1299 cells
were incubated for 18 h in the absence of serum and then treated with
indicated concentrations of dioscin for 24 h, after which the cells
were stained with PI and analyzed for DNA content by flow
cytometry. Furthermore, after being treated with different concentra-
tions of dioscin for 24 h, cells were harvested and then subjected to
quantitative analysis of cell apoptosis by annexin-V and PI double-
stained flow cytometry (c), or subjected to Western blotting with an
antibody against Bcl-2, PARP or caspase-3 antibody (d), as well as
cleaved caspase-8 and caspase-9 (e). b-Actin acting as an internal
control. f Cells were treated with 5 lM dioscin for 24 h in the
presence or absence of 2 lM Z-DEVE-FMK, 20 lM Z-IETD-FMK
and 20 lM Z-LEHD-FMK and then subjected to MTT assay to
determine cell viability. Results are shown as mean ± SD.
***P \ 0.001, control versus dioscin; #P \ 0.05, dioscin versus
Z-DEVE-FMK, Z-IETD-FMK and Z-LEHD-FMK plus dioscin
b
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prevents the fusion between lysosomes and autophago-
somes, was also used in the pretreatment. As shown in
Fig. 4d, cells pretreated with BafA1 were more susceptible
to dioscin (2.5 and 5 lM). A similar result was obtained in
the annexin-V staining assay. Cells treated for 24 h with
dioscin plus BafA1 showed an increased percentage of
annexin-V-positive cells (Fig. 4e). Therefore, inhibition of
autophagy could not inhibit dioscin-induced cell death, but
enhanced dioscin-induced apoptosis.
The autophagy induction by dioscin is dependent
on a regulation of PI3K/Akt and MAPK signaling
pathways in human lung cancer cell lines
Several signaling pathways have been implicated in the
regulation of autophagy (Lee et al. 2008; Dong et al. 2002).
In a further investigation into the underlying molecular
mechanisms, the phosphorylation of mTOR was examined
to show that dioscin treatment led to a decreased phos-
phorylation of mTOR (Fig. 5a, c). To investigate the pos-
sible role of MAPK pathways in dioscin-induced
autophagy, the expression levels of PI3K and phosphory-
lated forms of Akt, ERK1/2, p38MAPK and JNK1/2 were
examined by Western blotting. Results showed that the
expression of PI3K and phosphorylation of Akt were
decreased in cells treated with dioscin in a dose-dependent
manner. On the contrary, dioscin led to an activation of
ERK1/2 and JNK1/2 in a dose-dependent manner (Fig. 5b,
d). The results showed that dioscin could induce autophagy
by an up-regulation of ERK1/2 and JNK1/2 activation, as
well as a down-regulation of PI3K/Akt and mTOR
phosphorylation.
Discussion
Natural herbal products have a promising and potential role
in developing novel chemotherapeutics for various cancers
(Casciola-Rosen et al. 1996; Lee et al. 2008). Dioscin has
been extensively studied for its antitumor effect including
antiproliferative activities, cell cycle arrest and apoptosis
induction via the mitochondrial and some other pathways
(Cai et al. 2002; Wang et al. 2007a, b; Sun et al. 2011). Cai
et al. reported that after being treated with dioscin, caspase-
9 and caspase-3 activity was increased in Hela cells, and
the activity of caspase-8 did not change. However, another
study showed dioscin-induced FasL and FADD expression,
caspase-8 activation and Bid truncation in human myelo-
blast leukemia HL-60 cells. Results from our previous
study performed on A549 and H1299 cells indicated that
dioscin could significantly enhance the expression amounts
of cleaved caspase-3, caspase-8 and PARP. These results
suggested that the results of dioscin-induced caspase
expression may have cell type-specific correlation. Mean-
while, the expression of the antiapoptotic protein Bcl-2 also
was decreased. The findings are consistent with the apop-
tosis-inducing effects of dioscin on HeLa cells (Cai et al.
2002).
Autophagy is an important cellular response to numer-
ous diseases. Recently, autophagy has become a potential
and promising target in drug research for various diseases
and also be implicated in the pathogenesis related to can-
cers and diseases (Shintani and Klionsky 2004; Kondo
et al. 2005; Høyer-Hansen and Ja¨a¨ttela¨ 2008). Furthermore,
many anticancer agents were reported to induce autophagy
(Rosenfeldt and Ryan 2009). Sulforaphane causes autoph-
agy as a defense mechanism against apoptosis in PC3 and
LNCaP prostate cancer cells (Herman-Antosiewicz et al.
2006), while 7,700-dimethoxyagastisflavone (DMGF)
induced autophagic cell death in HepG2 cells (Hwang et al.
2012). The formation of vacuoles in dioscin-treated cells is
similar to cell autophagy (Kitanaka and Kuchino 1999), a
general phenomenon that occurs when cells respond to
stress. Autophagy is a type II programmed cell death and a
lysosomal degradation pathway essential for homeostasis
(Kelekar 2005). When autophagy is induced, beclin-1 and
LC3 distribute to the membrane of autophagosomes that
are correlated to the extent of autophagosome formation
(Kelekar 2005). In this study, dioscin induced autophagy as
early as 12 h after the addition of dioscin, and results from
the analysis of LC3-II expression indicated that the
induction of autophagy was dose-dependent (Fig. 3).
Previous studies have suggested that autophagy can be
induced by various compounds and involved in cell death
or cytoprotection in HCC cells (Chua and Choo 2011).
Autophagy is genetically programmed, and promoters of
autophagy are clinically beneficial in the setting of cancer
prevention. With autophagy inhibitors, 3-MA and BafA1,
the role of autophagy in dioscin-induced cell death was
further investigated. The dioscin-induced inhibition of
LC3-II, as well as increase in procaspase-3 and procaspase-
8 cleavage levels, and subsequently increased cell death
were conversed by 3-MA (Fig. 4). Therefore, we
Fig. 3 Induction of autophagy in dioscin-treated human lung cancer
cell lines. a A549 and H1299 cells were treated with 1.25, 2.5 and
5 lM dioscin for 12 h and then observed under microscope to reveal
the formation of various numbers of vacuoles in cell cytoplasm.
b A549 and H1299 cells were treated with 5 lM dioscin for 12 h,
followed by immunostaining and an observation of LC-3 (green
fluorescence) and DAPI (blue fluorescence) under fluorescence
microscopy. c The percentage of cells with the formation of AVOs
was calculated based on the results of fluorescence-activated cell
sorting assay. d Cells were treated with an indicated concentration of
dioscin (0–5 lM) for 12 h and then subjected to Western blotting to
study the expression levels of LC3-I, LC3-II and beclin-1 with b-actin
acting as an internal control. Results are shown as mean ± SD.
***P \ 0.001, control versus dioscin
b
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Fig. 4 Effect of autophagy
inhibitors on dioscin-induced
human lung cancer cell death.
A549 and H1299 cells were
treated for 24 h with 5 lM
dioscin with or without a 1 hour
pretreatment of 5 mM 3-MA.
The expression of LC3-II,
cleaved caspase-3 and cleaved
caspase-8 was detected by
Western blotting (a), cell
viability was determined by
MTT assay (b), together with
annexin-V and PI double-
staining flow cytometry (c).
Subsequently, A549 and H1299
cells were treated with different
concentration of dioscin for
24 h with or without a
pretreatment of 10 nM BafA1.
Afterward, treated cells were
subjected to MTT assay for cell
viability (d), double-staining
with annexin-V and PI and flow
cytometry (e). Results are
shown as mean ± SD.
*P \ 0.05, **P \ 0.01,
***P \ 0.001, dioscin versus
3-MA or BafA1 plus dioscin
1934 Arch Toxicol (2013) 87:1927–1937
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hypothesized that an inhibition of autophagy could not
decrease, but rather enhance, dioscin-induced cell death.
Furthermore, a treatment with caspase inhibitor alone led
to a limited recovery of cell viability (Fig. 2f), suggesting
that autophagy serves as a critical defensive mechanism
against common chemotherapeutic agents in A549 and
H1299 cell lines.
For a better understanding of dioscin-induced cytotox-
icity, the downstream effects of dioscin were further
defined. As autophagy is required for the effective man-
agement of metabolic stress, promoting autophagy through
mTOR pathway inhibition is reasonably expected to limit
tumor progression (Rimando et al. 2004). The PI3K/Akt
and mTOR/p70S6K pathways are main pathways that
negatively regulate autophagy (Suh et al. 2007). This study
demonstrated that the mechanism of dioscin-induced
autophagy of A549 and H1299 cells through an inhibition
of PI3K/Akt/mTOR pathways and activation of ERK1/2
and JNK1/2 signal pathway (Fig. 5).
In conclusion, through this study, we demonstrated that
dioscin suppressed cell growth and induced apoptosis in
A549 and H1299 cells. Autophagy has been regarded as a
Fig. 5 Dioscin inhibits the
mTOR, PI3K and Akt and
activates the ERK1/2 and JNK1/
2 in human lung cancer cell
lines. Cells were treated with
different concentrations of
dioscin (0–5 lM) for 24 h and
then subjected to Western
blotting with an antibody
against phospho-mTOR,
phospho-PI3K or phosphor-Akt
(a, c). The levels of
phosphorylation of ERK1/2,
JNK1/2 and p38 were also
investigated by Western blotting
with b-actin being used as an
internal control (b, d). The
values under each lane indicate
relative density of the band
normalized to b-actin using a
densitometer
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double-edged sword in cancer development, progression
and responses to treatment (Lozy and Karantza 2012).
Previous studies showed that an induction of autophagy
appears to facilitate therapy-induced killing of tumor cells
(Longo et al. 2008; Ko et al. 2009). Otherwise, the later has
been shown to be due to its role in generating glycolytic
substrates through recycling damaged organelles and
mutant and unfolded proteins, thereby providing survival
advantage to cancer cells under nutrition starvation and
cellular stress (Lozy and Karantza 2012). In our study,
dioscin induced autophagy in the early stage of dioscin-
induced apoptosis, leading to a suggestion that autophagy
protects cancer cells from the anticancer activity of dioscin.
We also found that dioscin induced autophagy through an
inhibition of the PI3K/Akt/mTOR and an activation of
ERK1/2 and JNK1/2 signal pathway. With the ability to
induce apoptotic and autophagic effects, dioscin has
promising anticancer properties in human lung cell lines.
Therefore, dioscin may act as a new and potential anti-
cancer agent for human lung cancer cell lines.
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